Literature DB >> 1586526

Patient compliance with colorectal cancer screening in general practice.

D Mant1, A Fuller, J Northover, P Astrop, A Chivers, A Crockett, S Clements, M Lawrence.   

Abstract

A randomized controlled trial to test patient compliance with screening for colorectal cancer in association with general practice health checks was carried out in six practices (three urban and three rural). A total of 1588 patients aged 45-64 years were randomized to one of four intervention groups. In the first group patients were posted a Haemoccult test (Kline Beckman) kit. This group was not invited for a health check. In the second group patients were posted the Haemoccult test kit, together with an invitation to attend for a health check. In the third group patients were posted an invitation for a health check, which explained that the patient would be offered the Haemoccult test kit by the nurse at the health check. In the fourth group patients were just invited for a health check. It was found that combining faecal occult blood testing with the health check did not reduce attendance at the health check--43.5% of patients attended when the Haemoccult test kit was offered by the nurse at the health check, 43.6% attended when a test kit was included with the invitation to attend the health check and 42.9% attended when the health check invitation was posted on its own. Overall, compliance with Haemoccult testing was not significantly increased by associating it with a health check (26.2% versus 25.5%) but compliance was higher when the faecal occult blood testing kit was enclosed with the health check invitation than when it was offered at the health check (31.7% versus 20.6%, P less than 0.001). It is easier and cheaper to combine various screening procedures. Although the overall use of the Haemoccult test in the study population was low, there is no reason why the relatively higher compliance rate obtained on posting the test kit with a health check invitation cannot be achieved in previously unscreened populations with higher expected compliance rates. However, faecal occult blood screening for colorectal cancer should not be undertaken on a population basis until its effectiveness in reducing mortality has been proven by randomized trial.

Entities:  

Mesh:

Year:  1992        PMID: 1586526      PMCID: PMC1371962     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  6 in total

1.  Compliance with screening for colorectal cancer.

Authors:  H S Cuckle; N J Wald; E B Butler
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-06

2.  Randomised trial of compliance with screening for colorectal cancer.

Authors:  S Nichols; E Koch; R C Lallemand; R J Heald; L Izzard; D Machin; M A Mullee
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

Review 3.  Participation in fecal occult blood screening: a critical review.

Authors:  S J Blalock; B M DeVellis; R S Sandler
Journal:  Prev Med       Date:  1987-01       Impact factor: 4.018

4.  Facilitating prevention in primary care.

Authors:  E Fullard; G Fowler; M Gray
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-08

5.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

6.  Health checks in general practice: another example of inverse care?

Authors:  D Waller; M Agass; D Mant; A Coulter; A Fuller; L Jones
Journal:  BMJ       Date:  1990-04-28
  6 in total
  20 in total

1.  The health of the nation from a local perspective.

Authors:  D Cox
Journal:  Br J Gen Pract       Date:  1992-05       Impact factor: 5.386

2.  Results of a community-based randomized trial to increase colorectal cancer screening among Filipino Americans.

Authors:  Annette E Maxwell; Roshan Bastani; Leda L Danao; Cynthia Antonio; Gabriel M Garcia; Catherine M Crespi
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 9.308

3.  Telephone outreach to increase colorectal cancer screening in an urban minority population.

Authors:  Charles E Basch; Randi L Wolf; Corey H Brouse; Celia Shmukler; Alfred Neugut; Lawrence T DeCarlo; Steven Shea
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

Review 4.  Decision making in colorectal cancer screening.

Authors:  E Trowers; W Nguyen; E Cobos
Journal:  J Natl Med Assoc       Date:  1997-01       Impact factor: 1.798

Review 5.  Organizational factors and the cancer screening process.

Authors:  Rebecca Anhang Price; Jane Zapka; Heather Edwards; Stephen H Taplin
Journal:  J Natl Cancer Inst Monogr       Date:  2010

6.  Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.

Authors:  A R Hart; J Eaden; S Barnett; A M de Bono; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1998-12       Impact factor: 3.710

7.  Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.

Authors:  Cédric Rat; Corinne Pogu; Delphine Le Donné; Chloé Latour; Gaelle Bianco; France Nanin; Anne Cowppli-Bony; Aurélie Gaultier; Jean-Michel Nguyen
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

8.  Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.

Authors:  Chloé Maréchal; Isabelle Aimone-Gastin; Cédric Baumann; Bastien Dirrenberger; Jean-Louis Guéant; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2017-02-06       Impact factor: 4.623

9.  An industry based approach to colorectal cancer screening in an asymptomatic population.

Authors:  A R Hart; N Glover; J Howick-Baker; J F Mayberry
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

10.  Screening for colorectal cancer.

Authors:  J Austoker
Journal:  BMJ       Date:  1994-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.